NEW DRUG-PROTEIN CONJUGATES AND ANTIBODY IMMUNOCONJUGATES FOR TARGETED THERAPY AND DIAGNOSIS.

Summary: New drugs have been spotted to design and produce drug-protein conjugates, drug-antibody conjugates and other immunoconjugates to many useful bioactive molecules such as monoclonal antibodies and their derivatives.

Fields of the invention: Therapy and diagnosis of cancer and other diseases, biotechnology, pharmacology, immunology, etc.

We are looking for development partners.

CONTACT

Links:

MONOCLONAL ANTIBODY INDEX and VACCINE ANTIGEN INDEX

ALGORIMUT©: MUTATION PREDICTION ALGORITHM

QUANTITATIVE SINGLE-CELL PROTEOMICS

NEW BIOMARKER DISCOVERY AND IDENTIFICATION SYSTEM.